Financhill
Back

Zealand Pharma AS Quote, Financials, Valuation and Earnings

Zealand Pharma AS Price Quote

$118.11
-2.07 (-1.72%)
(Updated: November 13, 2024 at 9:50 AM ET)

Zealand Pharma AS Key Stats

Sell
49
Zealand Pharma AS (ZLDPF) is a Sell

Day range:
$118.89 - $121.00
52-week range:
$41.66 - $141.74
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
684.02
P/B ratio:
6.38%

Volume:
1.2K
Avg. volume:
1.2K
1-year change:
197.48%
Market cap:
$8.5B
Revenue:
$49.8M
EPS:
$-2.43

How Much Does Zealand Pharma AS Make?

Is Zealand Pharma AS Growing As A Company?

  • What Is Zealand Pharma AS's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.98%
  • What Is Zealand Pharma AS's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Zealand Pharma AS Stock Price Performance

What Is Zealand Pharma AS 52-Week High & Low?

Zealand Pharma AS Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Zealand Pharma AS?

  • How Much Debt Does Zealand Pharma AS Have?
    Total long term debt quarterly is $42.1M
  • How Much Cash Does Zealand Pharma AS Have?
    Cash and short term investments quarterly total is $1.3B
  • What Is Zealand Pharma AS’s Book Value Per Share?
    Book value per share is 18.83

Is Zealand Pharma AS Cash Flow Positive?

  • What Is ZLDPF Cash Flow From Operations?
    Cash flow from operations (TTM) is -$101.5M
  • What Is Zealand Pharma AS’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.2B
  • What Is Zealand Pharma AS’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.1B

Zealand Pharma AS Return On Invested Capital

  • Is Management Doing A Good Job?
    ZLDPF return on invested capital is -20.65%
  • What Is Zealand Pharma AS Return On Assets?
    ROA measures how assets are converting to revenues and is -19.03%
  • What Is ZLDPF Return On Equity?
    ROE is a measure of profitability and is -21.35%

Zealand Pharma AS Earnings Date & Stock Price

Zealand Pharma AS Competitors

Zealand Pharma AS Dividend Yield

Zealand Pharma AS Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -98.49% -91.85%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 22.50
Downside from Last Price: -81.28%

Major Shareholders

  • How many ZLDPF shares are owned by institutional investors?
    22.8M ZLDPF shares are owned by institutional investors
  • How many ZLDPF shares are owned by insiders?
    0 ZLDPF shares are owned by insiders